Table 1.
Correlation between MIR99AHG expression and clinicopathological characteristics of GC
| Clinical parameter | MIR99AHG | Expression | P-value |
|---|---|---|---|
| High no. cases (n = 59) | Low no. cases (n = 59) | ||
| Age (years) | 0.732 | ||
| ≤ 50 | 31 | 36 | |
| > 50 | 28 | 23 | |
| Gender | 0.554 | ||
| Male | 37 | 33 | |
| Female | 22 | 27 | |
| Location | 0.679 | ||
| Distal | 20 | 24 | |
| Middle | 21 | 23 | |
| Proximal | 18 | 12 | |
| Size (cm) | 0.654 | ||
| > 5 | 35 | 33 | |
| ≤ 5 | 29 | 31 | |
| Histologic differentiation | 0.008 | ||
| Well | 9 | 13 | |
| Moderately | 17 | 20 | |
| Poorly | 21 | 10 | |
| Undifferentiated | 12 | 16 | |
| Invasion depth | < 0.001 | ||
| T1 | 4 | 15 | |
| T2 | 10 | 21 | |
| T3 | 20 | 15 | |
| T4 | 15 | 8 | |
| TNM stages | 0.003 | ||
| I–II | 20 | 35 | |
| III–IV | 39 | 24 | |
| Lymphatic metastasis | < 0.001 | ||
| Yes | 39 | 23 | |
| No | 20 | 36 | |
| Distant metastasis | 0.02 | ||
| Yes | 15 | 7 | |
| No | 44 | 52 | |